Month: August 2024

Millicom’s (Tigo) Independent Committee Reviewing Revised Tender Offers from Atlas Luxco S.à r.lLuxembourg, August 06, 2024 – On August 2,...

Second quarter 2024 U.S. BRIUMVI net revenue of $72.6 millionRaising full year 2024 U.S. BRIUMVI net revenue target to approximately...

CHAPEL HILL, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (the “Company” or “Tenax Therapeutics”), a...

Tim Laczkowski Appointed to Lead Texas Capital’s Inaugural Direct Lending FundDALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares,...

More than 6 million active-duty & retired military personnel, along with partners and dependents, will now have access to Talkspace’s...

NEW YORK and RIYADH, Saudi Arabia, Aug. 6, 2024 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform...

Files voluntary Chapter 11 petitions to effectuate the proposed transaction Intends to operate Blue Raven Solar and New Homes through...

Sapiens' automation of the reinsurer's processes ensures financial stability and operational excellence ROCHELLE PARK, N.J., Aug. 6, 2024 /PRNewswire/ --...

Camarillo, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Sacks Parente Golf, Inc. (NASDAQ: SPGC), (the “Company” or “Sacks Parente”), a...

Strength in U.S. Growth Offset by Challenges in BioPharma and EMEA; Strong Cost Management Buffers Loss BOSTON and ROLLE, Switzerland,...

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company...

Ivonescimab Monotherapy Achieved Statistically Significant & Clinically Meaningful Improvement over Pembrolizumab Monotherapy Head-to-Head in HARMONi-2 Phase III Trial in 1L...

Contacts Investor Relations investorrelations@sidusspace.com Media Inquiries press@sidusspace.com Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), a provider of end-to-end precision...

With an Expected Launch in Early Q4, Safety Shot Powder Stick Packets Will Address an Anticipated $517M Market SizeJUPITER, Fla.,...

CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that...

CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that...

Former White House Top Health Security Official to Lead Flagship's Preemptive Health and Medicine Initiative CAMBRIDGE, Mass., Aug. 6, 2024...

MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company...

MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company...

Second rare disease program with RZ358 in Phase 3 developmentFollows successful treatment of multiple patients with tumor hyperinsulinism under the...

-- Second quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $29.1 million ---- Dosed first patients in...

SANDIEGO, CA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of...

BOSTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today...

Contacts Press Enquiries Shilpa Narani | shilpa.narani@renew.com Investor Enquiries Nathan Judge, Anunay Shahi, Nitin Vaid | ir@renew.com ReNew Energy Global...

CORAL GABLES, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”), a late-stage biotechnology company addressing...

New orders across multiple customers and products provide increasing evidence of RFI's market opportunity SAN DIEGO, CA / ACCESSWIRE /...

Access to healthcare services, restaurants, bars and coffee shops top the list of trade-offs house hunters are willing to make...

Total investment income increased 18% to $2.1 million for the quarter compared with the second quarter last year driven by...

Announces Participation in Upcoming Investor Conferences SAN JOSE, Calif., Aug. 5, 2024 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), a developer...

Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cureInitial clinical site and pediatric patient identified...

JNJ-2113 Phase 3 ICONIC-LEAD and Phase 3 ICONIC-TOTAL clinical trials in moderate-to-severe plaque psoriasis expected to complete the primary endpoint...

Industry veteran with more than 25 years of experience further strengthens Pagaya’s executive leadership team and deepens capital markets, monetization,...

NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company,...

Origin caps make recycling easier with “mono-material” containers, can be made with unmodified virgin PET plastic or 100% recycled PET...

Origin caps make recycling easier with “mono-material” containers, can be made with unmodified virgin PET plastic or 100% recycled PET...

CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the...

NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial...

LONDON and NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

Contacts For Media enquiries: Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs megan.mccrae@organigram.ca For Investor Relations enquiries:...

Contacts Investor Relations Julie Dewey, Chief Investor Relations and Communications Officer JulieDewey@Orthofix.com (209) 613-6945 Media Relations Denise Landry, Vice President,...